Skip to main content
Top
Published in: Diabetologia 1/2014

01-01-2014 | Article

Characterising metabolically healthy obesity in weight-discordant monozygotic twins

Authors: J. Naukkarinen, S. Heinonen, A. Hakkarainen, J. Lundbom, K. Vuolteenaho, L. Saarinen, S. Hautaniemi, A. Rodriguez, G. Frühbeck, P. Pajunen, T. Hyötyläinen, M. Orešič, E. Moilanen, A. Suomalainen, N. Lundbom, J. Kaprio, A. Rissanen, K. H. Pietiläinen

Published in: Diabetologia | Issue 1/2014

Login to get access

Abstract

Aims/hypothesis

Not all obese individuals display the metabolic disturbances commonly associated with excess fat accumulation. Mechanisms maintaining this ‘metabolically healthy obesity’ (MHO) are as yet unknown. We aimed to study different fat depots and transcriptional pathways in subcutaneous adipose tissue (SAT) as related to the MHO phenomenon.

Methods

Sixteen rare young adult obesity-discordant monozygotic (MZ) twin pairs (intra-pair difference (∆) in BMI ≥3 kg/m2), aged 22.8–35.8 years, were examined for detailed characteristics of metabolic health (subcutaneous, intra-abdominal and liver fat [magnetic resonance imaging/spectroscopy]), OGTT, lipids, adipokines and C-reactive protein (CRP). Affymetrix U133 Plus 2.0 chips were used to analyse transcriptomics pathways related to mitochondrial function and inflammation in SAT.

Results

Based on liver fat accumulation, two metabolically different subgroups emerged. In half (8/16) of the pairs (∆weight 17.1 ± 2.0 kg), the obese co-twin had significantly higher liver fat (∆718%), 78% increase in AUC insulin during OGTT and CRP, significantly more disturbance in the lipid profile and greater tendency for hypertension compared with the lean co-twin. In these obese co-twins, SAT expression of mitochondrial oxidative phosphorylation, branched-chain amino acid catabolism, fatty acid oxidation and adipocyte differentiation pathways were downregulated and chronic inflammation upregulated. In the other eight pairs (∆weight 17.4 ± 2.8 kg), the obese co-twin did not differ from the non-obese co-twin in liver fat (∆8%), insulin sensitivity, CRP, lipids, blood pressure or SAT transcriptomics.

Conclusions/interpretation

Our results suggest that maintenance of high mitochondrial transcription and lack of inflammation in SAT are associated with low liver fat and MHO.
Appendix
Available only for authorised users
Literature
1.
go back to reference Primeau V, Coderre L, Karelis AD et al (2010) Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (2005) 35:971–981CrossRef Primeau V, Coderre L, Karelis AD et al (2010) Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (2005) 35:971–981CrossRef
2.
go back to reference Bluher M (2010) The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 21:38–43CrossRefPubMed Bluher M (2010) The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 21:38–43CrossRefPubMed
3.
go back to reference Wildman RP, Muntner P, Reynolds K et al (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 168:1617–1624CrossRefPubMed Wildman RP, Muntner P, Reynolds K et al (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 168:1617–1624CrossRefPubMed
4.
go back to reference Samocha-Bonet D, Chisholm DJ, Tonks K, Campbell LV, Greenfield JR (2012) Insulin-sensitive obesity in humans—a ‘favorable fat’ phenotype? Trends Endocrinol Metab 23:116–124CrossRefPubMed Samocha-Bonet D, Chisholm DJ, Tonks K, Campbell LV, Greenfield JR (2012) Insulin-sensitive obesity in humans—a ‘favorable fat’ phenotype? Trends Endocrinol Metab 23:116–124CrossRefPubMed
5.
go back to reference Jennings CL, Lambert EV, Collins M, Joffe Y, Levitt NS, Goedecke JH (2008) Determinants of insulin-resistant phenotypes in normal-weight and obese Black African women. Obesity (Silver Spring) 16:1602–1609CrossRef Jennings CL, Lambert EV, Collins M, Joffe Y, Levitt NS, Goedecke JH (2008) Determinants of insulin-resistant phenotypes in normal-weight and obese Black African women. Obesity (Silver Spring) 16:1602–1609CrossRef
6.
go back to reference Messier V, Karelis AD, Prud’homme D, Primeau V, Brochu M, Rabasa-Lhoret R (2010) Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity (Silver Spring) 18:911–917CrossRef Messier V, Karelis AD, Prud’homme D, Primeau V, Brochu M, Rabasa-Lhoret R (2010) Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity (Silver Spring) 18:911–917CrossRef
7.
go back to reference Weiss R, Taksali SE, Dufour S et al (2005) The “obese insulin-sensitive” adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metabol 90:3731–3737CrossRef Weiss R, Taksali SE, Dufour S et al (2005) The “obese insulin-sensitive” adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metabol 90:3731–3737CrossRef
8.
go back to reference Brochu M, Tchernof A, Dionne IJ et al (2001) What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metabol 86:1020–1025CrossRef Brochu M, Tchernof A, Dionne IJ et al (2001) What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metabol 86:1020–1025CrossRef
9.
go back to reference Karelis AD, Faraj M, Bastard JP et al (2005) The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metabol 90:4145–4150CrossRef Karelis AD, Faraj M, Bastard JP et al (2005) The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metabol 90:4145–4150CrossRef
10.
go back to reference Kloting N, Fasshauer M, Dietrich A et al (2010) Insulin-sensitive obesity. Am J Physiol 299:E506–E515CrossRef Kloting N, Fasshauer M, Dietrich A et al (2010) Insulin-sensitive obesity. Am J Physiol 299:E506–E515CrossRef
11.
go back to reference Messier V, Karelis AD, Robillard ME et al (2010) Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metab Clin Exp 59:20–24CrossRefPubMed Messier V, Karelis AD, Robillard ME et al (2010) Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metab Clin Exp 59:20–24CrossRefPubMed
12.
go back to reference Stefan N, Kantartzis K, Machann J et al (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609–1616CrossRefPubMed Stefan N, Kantartzis K, Machann J et al (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609–1616CrossRefPubMed
13.
go back to reference Coen PM, Dube JJ, Amati F et al (2010) Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 59:80–88CrossRefPubMed Coen PM, Dube JJ, Amati F et al (2010) Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 59:80–88CrossRefPubMed
14.
go back to reference Fabbrini E, Magkos F, Mohammed BS et al (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106:15430–15435CrossRefPubMed Fabbrini E, Magkos F, Mohammed BS et al (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106:15430–15435CrossRefPubMed
15.
go back to reference D’Adamo E, Cali AM, Weiss R et al (2010) Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 33:1817–1822CrossRefPubMed D’Adamo E, Cali AM, Weiss R et al (2010) Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 33:1817–1822CrossRefPubMed
16.
go back to reference Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology (Baltimore) 42:44–52CrossRef Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology (Baltimore) 42:44–52CrossRef
17.
go back to reference Heilbronn L, Smith SR, Ravussin E (2004) Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 28(Suppl 4):S12–S21CrossRefPubMed Heilbronn L, Smith SR, Ravussin E (2004) Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 28(Suppl 4):S12–S21CrossRefPubMed
18.
go back to reference Capeau J, Magre J, Lascols O et al (2005) Diseases of adipose tissue: genetic and acquired lipodystrophies. Biochem Soc Trans 33:1073–1077CrossRefPubMed Capeau J, Magre J, Lascols O et al (2005) Diseases of adipose tissue: genetic and acquired lipodystrophies. Biochem Soc Trans 33:1073–1077CrossRefPubMed
19.
go back to reference McQuaid SE, Hodson L, Neville MJ et al (2011) Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 60:47–55CrossRefPubMed McQuaid SE, Hodson L, Neville MJ et al (2011) Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 60:47–55CrossRefPubMed
20.
go back to reference Alligier M, Gabert L, Meugnier E et al (2013) Visceral fat accumulation during lipid overfeeding is related to subcutaneous adipose tissue characteristics in healthy men. J Clin Endocrinol Metabol 98:802–810CrossRef Alligier M, Gabert L, Meugnier E et al (2013) Visceral fat accumulation during lipid overfeeding is related to subcutaneous adipose tissue characteristics in healthy men. J Clin Endocrinol Metabol 98:802–810CrossRef
21.
go back to reference De Pauw A, Tejerina S, Raes M, Keijer J, Arnould T (2009) Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am J Pathol 175:927–939CrossRefPubMed De Pauw A, Tejerina S, Raes M, Keijer J, Arnould T (2009) Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am J Pathol 175:927–939CrossRefPubMed
22.
go back to reference Kaaman M, Sparks LM, van Harmelen V et al (2007) Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue. Diabetologia 50:2526–2533CrossRefPubMed Kaaman M, Sparks LM, van Harmelen V et al (2007) Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue. Diabetologia 50:2526–2533CrossRefPubMed
23.
go back to reference Medina-Gomez G (2012) Mitochondria and endocrine function of adipose tissue. Best Pract Res 26:791–804CrossRef Medina-Gomez G (2012) Mitochondria and endocrine function of adipose tissue. Best Pract Res 26:791–804CrossRef
24.
go back to reference Pietiläinen KH, Naukkarinen J, Rissanen A et al (2008) Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 5:e51CrossRefPubMed Pietiläinen KH, Naukkarinen J, Rissanen A et al (2008) Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 5:e51CrossRefPubMed
25.
go back to reference Mustelin L, Pietiläinen KH, Rissanen A et al (2008) Acquired obesity and poor physical fitness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity. Am J Physiol 295:E148–E154 Mustelin L, Pietiläinen KH, Rissanen A et al (2008) Acquired obesity and poor physical fitness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity. Am J Physiol 295:E148–E154
26.
go back to reference Kolak M, Westerbacka J, Velagapudi VR et al (2007) Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 56:1960–1968CrossRefPubMed Kolak M, Westerbacka J, Velagapudi VR et al (2007) Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 56:1960–1968CrossRefPubMed
27.
go back to reference Naukkarinen J, Rissanen A, Kaprio J, Pietiläinen KH (2012) Causes and consequences of obesity: the contribution of recent twin studies. Int J Obes (London) 36:1017–1024CrossRef Naukkarinen J, Rissanen A, Kaprio J, Pietiläinen KH (2012) Causes and consequences of obesity: the contribution of recent twin studies. Int J Obes (London) 36:1017–1024CrossRef
29.
go back to reference Graner M, Seppälä-Lindroos A, Rissanen A et al (2012) Epicardial fat, cardiac dimensions, and low-grade inflammation in young adult monozygotic twins discordant for obesity. Am J Cardiol 109:1295–1302CrossRefPubMed Graner M, Seppälä-Lindroos A, Rissanen A et al (2012) Epicardial fat, cardiac dimensions, and low-grade inflammation in young adult monozygotic twins discordant for obesity. Am J Cardiol 109:1295–1302CrossRefPubMed
30.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
31.
go back to reference Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRefPubMed Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRefPubMed
32.
go back to reference Yeckel CW, Weiss R, Dziura J et al (2004) Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metabol 89:1096–1101CrossRef Yeckel CW, Weiss R, Dziura J et al (2004) Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metabol 89:1096–1101CrossRef
33.
go back to reference Castillo S, Mattila I, Miettinen J, Oresic M, Hyotylainen T (2011) Data analysis tool for comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry. Anal Chem 83:3058–3067CrossRefPubMed Castillo S, Mattila I, Miettinen J, Oresic M, Hyotylainen T (2011) Data analysis tool for comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry. Anal Chem 83:3058–3067CrossRefPubMed
34.
go back to reference Hirsch J, Gallian E (1968) Methods for the determination of adipose cell size in man and animals. J Lipid Res 9:110–119PubMed Hirsch J, Gallian E (1968) Methods for the determination of adipose cell size in man and animals. J Lipid Res 9:110–119PubMed
35.
go back to reference Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936–942PubMed Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936–942PubMed
36.
go back to reference Ovaska K, Laakso M, Haapa-Paananen S et al (2010) Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genom Med 2:65CrossRef Ovaska K, Laakso M, Haapa-Paananen S et al (2010) Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genom Med 2:65CrossRef
37.
go back to reference R Development Core Team (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna R Development Core Team (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
38.
go back to reference Agarwal AK, Garg A (2003) Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. Trends Endocrinol Metab 14:214–221CrossRefPubMed Agarwal AK, Garg A (2003) Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. Trends Endocrinol Metab 14:214–221CrossRefPubMed
39.
go back to reference Fassina G, Dorigo P, Gaion RM (1974) Equilibrium between metabolic pathways producing energy: a key factor in regulating lipolysis. Pharmacol Res Commun 6:1–21CrossRefPubMed Fassina G, Dorigo P, Gaion RM (1974) Equilibrium between metabolic pathways producing energy: a key factor in regulating lipolysis. Pharmacol Res Commun 6:1–21CrossRefPubMed
40.
go back to reference Sunny NE, Parks EJ, Browning JD, Burgess SC (2011) Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 14:804–810CrossRefPubMed Sunny NE, Parks EJ, Browning JD, Burgess SC (2011) Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 14:804–810CrossRefPubMed
41.
go back to reference Hackl H, Burkard TR, Sturn A et al (2005) Molecular processes during fat cell development revealed by gene expression profiling and functional annotation. Genome Biol 6:R108CrossRefPubMed Hackl H, Burkard TR, Sturn A et al (2005) Molecular processes during fat cell development revealed by gene expression profiling and functional annotation. Genome Biol 6:R108CrossRefPubMed
42.
go back to reference Lynch CJ, Halle B, Fujii H et al (2003) Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR. Am J Physiol 285:E854–E863 Lynch CJ, Halle B, Fujii H et al (2003) Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR. Am J Physiol 285:E854–E863
43.
go back to reference Herman MA, She P, Peroni OD, Lynch CJ, Kahn BB (2010) Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J Biol Chem 285:11348–11356CrossRefPubMed Herman MA, She P, Peroni OD, Lynch CJ, Kahn BB (2010) Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J Biol Chem 285:11348–11356CrossRefPubMed
44.
go back to reference Felig P, Marliss E, Cahill GF Jr (1969) Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281:811–816CrossRefPubMed Felig P, Marliss E, Cahill GF Jr (1969) Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281:811–816CrossRefPubMed
45.
go back to reference Wang TJ, Larson MG, Vasan RS et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448–453CrossRefPubMed Wang TJ, Larson MG, Vasan RS et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448–453CrossRefPubMed
46.
go back to reference Soronen J, Laurila PP, Naukkarinen J et al (2012) Adipose tissue gene expression analysis reveals changes in inflammatory, mitochondrial respiratory and lipid metabolic pathways in obese insulin-resistant subjects. BMC Med Genet 5:9 Soronen J, Laurila PP, Naukkarinen J et al (2012) Adipose tissue gene expression analysis reveals changes in inflammatory, mitochondrial respiratory and lipid metabolic pathways in obese insulin-resistant subjects. BMC Med Genet 5:9
47.
go back to reference Nomiyama T, Perez-Tilve D, Ogawa D et al (2007) Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 117:2877–2888CrossRefPubMed Nomiyama T, Perez-Tilve D, Ogawa D et al (2007) Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 117:2877–2888CrossRefPubMed
48.
go back to reference Arkan MC, Hevener AL, Greten FR et al (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11:191–198CrossRefPubMed Arkan MC, Hevener AL, Greten FR et al (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11:191–198CrossRefPubMed
49.
go back to reference Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610–614CrossRefPubMed Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610–614CrossRefPubMed
50.
go back to reference Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE (2010) The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med 152:346–357CrossRefPubMed Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE (2010) The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med 152:346–357CrossRefPubMed
Metadata
Title
Characterising metabolically healthy obesity in weight-discordant monozygotic twins
Authors
J. Naukkarinen
S. Heinonen
A. Hakkarainen
J. Lundbom
K. Vuolteenaho
L. Saarinen
S. Hautaniemi
A. Rodriguez
G. Frühbeck
P. Pajunen
T. Hyötyläinen
M. Orešič
E. Moilanen
A. Suomalainen
N. Lundbom
J. Kaprio
A. Rissanen
K. H. Pietiläinen
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 1/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3066-y

Other articles of this Issue 1/2014

Diabetologia 1/2014 Go to the issue